Abstract：Objective: To explore the correlation between heart rate variability (HRV) and PCT in children with Kawasaki disease and its value in predicting coronary artery injury. Methods: 86 cases of children with Kawasaki disease diagnosed in our hospital from January 2017 to June 2019 were retrospectively selected, including 46 male patients and 40 female patients, aged 1 to 5 years, average age 2.53 ± 1.14 years old. All children underwent echocardiography before treatment. According to whether coronary artery damage occurred, they were divided into group A (coronary artery damage group, 42 cases) and group B (non-coronary artery damage group, 44 cases). Healthy children served as a control group. HRV indicators (time domain indicators, frequency domain indicators) were tested for children in each group, and the serum PCT levels of children in each group were detected by immunofluorescence chromatography. The three groups of children's HRV time domain indicators and frequency domain indicators were observed and compared, and the PCT levels of children in each group were compared. Results: The results showed that children with Kawasaki disease compared with normal children in the control group had statistically significant differences in HRV time-domain and frequency-domain indicators (P<0.05), and children in group A had significantly lower HRV indicators than group B. The difference was statistically significant (P<0.05). The serum PCT levels of children in groups A and B were significantly higher than those in the control group, and the serum PCT levels (2.85 ± 1.28 ng / ml) in group A were significantly higher than those in group B (1.26 ± 0.93 ng / ml) (P<0.05). Conclusion: There is a good correlation between heart rate variability (HRV) and serum PCT levels in children with Kawasaki disease. At the same time, the above two indicators can more accurately predict whether children will have coronary artery injury. It has good diagnostic value and is suitable for the early clinical diagnosis of Kawasaki disease and Kawasaki disease combined with coronary artery injury, so as to provide a basis for the timely treatment of children. It is worthy of clinical promotion.
罗洁, 李晓忠, 闵月, 许秋艳, 董永超, 陆敏. 川崎病患儿心率变异性与PCT的相关性及其预测冠状动脉损伤的价值[J]. 河北医学, 2021, 27(7): 1215-1218.
LUO Jie, et al. Correlation Between Heart Rate Variability and PCT in Patients with Kawasaki Disease and Its Value in Predicting Coronary Artery Injury. HeBei Med, 2021, 27(7): 1215-1218.
[1] Wang Yu,Ma Yichen,Li Yan,et al.The clinical efficacy of dipyridamole in the treatment of kawasaki disease and its effect on the levels of CRP and PCT in children [J].Shaanxi Medical Journal,2018,47 (12): 1644~1647. [2] 黄小芹,林天植.丙种球蛋白应用时间对川崎病患儿退热时间以及冠状动脉损伤的影响[J].数理医药学杂志,2019,32(10):1530~1531. [3] Ma Xiaodan.Effect of application time of gamma globulin on fever time and coronary artery injury in children with Kawasaki disease [J].China Pharmaceutical Economics,2019,14 (8): 55~57. [4] 陈婷婷,石坤,柳颐龄,等.川崎病患儿心率变异性与冠状动脉损害的相关性研究[J].中国当代儿科杂志,2018,(6):607~612. [5] 韦海涛,汪希珂,陈林,等.不同剂量丙种球蛋白治疗丙种球蛋白无反应型川崎病患儿的临床疗效探讨[J].贵州医药,2019,43(8):1285~1288. [6] 曾俊峰,罗文秀,唐明生,等.川崎病急性期ESR、hs-CRP及PCT对冠脉损伤的意义分析[J].黑龙江中医药,2019,48(3):166~167. [7] 胡彬文,张丽娇,邓丽君,等.川崎病患者PCT治疗前后实验室指标观察[J].中国中医急症,2019,28(8):1450~1452. [8] Qiu Hong,Qiu Haiyan,Zhang Ruosong,et al.Clinical significance of detection of serum dicalcitonin,interleukin-6 and DD dimer in children with Kawasaki disease [J].Journal of Pediatric Pharmacy,2018,21 (6): 6~8. [9] 刘芳,李晓春.细胞因子谱、降钙素原、D-二聚体对预测小儿川崎病冠脉损伤的临床意义[J].安徽医药,2018,22(8):1499~1502. [10] 何玥薇,田杰,易岂建,等.血清降钙素原联合C反应蛋白对儿童川崎病并发冠状动脉损害的预测价值[J].中华妇幼临床医学杂志,2018,14(1):31~37.
2021, Vol. 27 
冀公网安备13080202000677号